Across disease status
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 1.170-1.937 | 1 |
| Healthy/control | 10-1.628 | 2 |
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 1.170-1.937 | 1 |
| Healthy/control | 10-1.628 | 2 |
How the same metric changes across tissue contexts after the current filters and tier are applied.
| Group | Median | Samples |
|---|---|---|
| Breast | 1.170-1.937 | 1 |
| Liver | 10-1.628 | 2 |
The combined comparison, useful for separating disease effects from tissue composition.
| Group | Median | Samples |
|---|---|---|
| Primary cancer x Breast | 1.170-1.937 | 1 |
| Healthy/control x Liver | 10-1.628 | 2 |
| Group | Metric | Mean | Samples | Datasets |
|---|---|---|---|---|
| Primary cancer | Mean propensity | 1.176 | 1 | 1 |
| Healthy/control | Mean propensity | 1.226 | 2 | 1 |